Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

P&O Ferries CEO Hebblethwaite to resign

(Sharecast News) - P&O Ferries, a subsidiary of DP World, confirmed on Friday that chief executive Peter Hebblethwaite was planning to resign. A spokesperson for the company said: "Peter Hebblethwaite has communicated his intention to resign from his position as chief executive officer to dedicate more time to family matters. P&O Ferries extends its gratitude to Peter Hebblethwaite for his contributions as CEO over the past four years.

"During his tenure the company navigated the challenges of the Covid-19 pandemic, initiated a path towards financial stability, and introduced the world's first large double-ended hybrid ferries on the Dover-Calais route, thereby enhancing sustainability. We extend our best wishes to him for his future endeavours."

The statement came after Sky News reported that Hebblethwaite had decided to resign for personal reasons.

Hebblethwaite - who in March 2022 sacked nearly 800 crew and replaced them with cheaper agency staff - was voted the "Worst Boss in the World" by trade unionists that year.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.